Ones To Watch News
Refine Search
Biotechnology
BioAge Labs today announced a multi-year research collaboration with Swiss pharma giant Novartis, with the news pushing the US biotech’s shares up 6.1% to $4.35 by early afternoon. 18 December 2024
Pharmaceutical
Marking its second deal this month alone, Novo Nordisk has entered into a multi-year collaboration with Massachusetts, USA-based Photys Therapeutics to develop novel proximity-based therapeutics for a cardiometabolic disease target. 18 December 2024
Biotechnology
Cara Therapeutics and Tvardi Therapeutics have announced a definitive agreement to merge, creating a new entity under the Tvardi name. 18 December 2024
Pharmaceutical
SiteOne Therapeutics has announced the completion of a $100 million series C financing, led by Novo Holdings, with participation from OrbiMed, Wellington Management, Mission BioCapital, and others. 18 December 2024
Biotechnology
Flagship Pioneering-founded genome engineering biotech Tessera Therapeutics today announced an investment of up to $50 million from the Bill & Melinda Gates Foundation to develop curative, globally accessible in vivo genetic therapies for sickle cell disease. 18 December 2024
Biotechnology
San Francisco-based Indapta Therapeutics, a privately held start-up developing next-generation cell therapies, has raised $22.5 million in a new financing round. The firm raised over $50 million in series A funding in 2022. 18 December 2024
Biotechnology
French CNS specialist Theranexus saw its shares leap more than 34% to 0.65 euros as it revealed a license and supply agreement with Exeltis to commercialize TX01, its novel formulation of a compound already approved in the indication for the treatment of rare neurological diseases. 18 December 2024
Biotechnology
Shares in US biopharma Viridian Therapeutics shot up by 21% on Monday. 17 December 2024
Biotechnology
US antivirals giant Gilead Sciences today revealed it has entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets with Californian biotech Terray Therapeutics. 17 December 2024
Pharmaceutical
Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private placement, supporting a planned expansion into the UK. 16 December 2024
Biotechnology
Dewpoint Therapeutics and ConcertAI have announced the first phase of their translational oncology partnership, aligned around the former company's latest drug candidate, DPTX3186. 16 December 2024
Biotechnology
Bicycle Therapeutics, a UK-headquartered pharma company developing a new class of therapeutics based on its proprietary bicyclic peptide technology, closed a third lower on Friday. 16 December 2024
Biotechnology
In a filing with the US financial regulator, German mRNA specialist BioNTech has noted the lifting of a partial clinical hold on its PRESERVE-003 trial. 16 December 2024
Biotechnology
VectorY Therapeutics, a Netherlands-based biotech focused on neurodegenerative diseases, has appointed Jim Scibetta as chief executive officer. 16 December 2024
Biotechnology
Sino-American biotech BeiGene has announced it has entered into a global licensing agreement with China’s CSPC Zhongqi Pharmaceutical Technology for SYH2039, a novel methionine adenosyltransferase 2A (MAT2A)-inhibitor being explored for solid tumors. 13 December 2024
Pharmaceutical
US biotech Corcept Therapeutics has reported positive results from the Phase IV CATALYST study of Korlym (mifepristone) in people with hypercortisolism and difficult-to-control type 2 diabetes. 13 December 2024
Biotechnology
Nine months out from landing an additional $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has announced a $45 million upfront deal, including a $15 million equity investment with UK pharma group GSK. 13 December 2024
Pharmaceutical
UK-based Tenpoint Therapeutics and Seattle’s Visus Therapeutics have announced the completion of their merger to create an entirely new chapter in ophthalmic therapeutic medicines aimed at rejuvenating the aging eye. 12 December 2024
Biotechnology
AI-driven biotech BenevolentAI has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. 12 December 2024
Biotechnology
USA-based Elevation Oncology, an innovative oncology company focused on the discovery and development of selective cancer therapies, has entered into a licensing agreement with Synaffix, part of Swiss out-sourcing major Lonza. 12 December 2024
Biotechnology
UK-based Barinthus Biotherapeutics today presented data from two hepatitis B virus (HBV) clinical trials at The American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting 2023. 10 November 2023
Biotechnology
UK oncology-focussed biotech ValiRx edged up 2.5% to 12.30 pence this morning, after it announced it has entered into an agreement with StingRay Bio to investigate a lead series of drug candidates for use in oncology. 10 November 2023
Biotechnology
A Phase II failure for Californian cell therapy company Atara Biotherapeutics has prompted a share sell-off, with the company’s stock falling 80% in value on Thursday. 10 November 2023
Biotechnology
A biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer, is to go by a new name. 7 November 2023
Biotechnology
A collaboration between Senti Biosciences and Celest Therapeutics will see the latter gain rights to develop SENTI-301A in China. 7 November 2023
Biotechnology
Having previously had disappointing results from its investigational drug, Kodiak Sciences yesterday announced that its Phase III GLOW superiority study evaluating tarcocimab tedromer 5mg in moderately severe to severe non-proliferative diabetic retinopathy (NPDR) met its one-year primary endpoint. 7 November 2023
Pharmaceutical
UK-headquartered specialty pharmaceutical company Advanz Pharma today announced it expands its specialty brands portfolio with the signing of the acquisition of global rights of Androcur (cyproterone acetate) from German pharma major Bayer. 7 November 2023
Biotechnology
Acelyrin has appointed Patricia Turney as chief technical operations officer. 6 November 2023
Biotechnology
Kronos Bio is to cut around 19% of its staff as part of a plan to extend its cash runway into 2026. 6 November 2023
Biotechnology
Shares of German biotech BioNTech were up 5.3% at $100.91, despite joining the list of companies with downturned sales and earnings as the COVID-19 pandemic subsides. 6 November 2023
Biotechnology
Halozyme Therapeutics today announced a global collaboration and non-exclusive license agreement with fellow US biotech Acumen Pharmaceuticals. 6 November 2023
Biotechnology
Australian inflammatory diseases specialist Dimerix has received an initial payment of 6.5 million euros ($7 million) in line with the recently-announced license agreement with Advanz Pharma. 6 November 2023
Biotechnology
In another antibody-drug conjugate (ADC) deal for the US pharma major, Bristol Myers Squibb has acquired USA and South Korea-based Orum Therapeutics’ ORM-6151 program. 6 November 2023
Biotechnology
UK-based biotech Roquefort Therapeutics has announced that its mesodermal killer (MK) cell program has reached a significant milestone. 6 November 2023
Biotechnology
Swiss biotech MoonLake Immunotherapeutics has announced positive top-line results from its global Phase II ARGO trial evaluating the efficacy and safety of the Nanobody sonelokimab in patients with active psoriatic arthritis (PsA). 6 November 2023
Biotechnology
Swiss biotech Idorsia yesterday released further data for aprocitentan, the firm’s investigational dual endothelin receptor antagonist for the treatment of patients with resistant hypertension, at the American Society of Nephrology (ASN) Kidney Week 2023. 4 November 2023
Biotechnology
Lexeo Therapeutics has announced the final pricing of its initial public offering of 9,090,910 shares of common stock at a price to the public of $11.00 per share. 3 November 2023
Biotechnology
Independent French drugmaker Pierre Fabre has expanded a global partnership for Ebvallo (tabelecleucel) with US biotech Atara Biotherapeutics. 3 November 2023
Biotechnology
US biotech BioMarin Pharmaceutical announced that Alexander Hardy has been named as the company’s president and chief executive. 3 November 2023
Biotechnology
San Diego, USA-based precision medicine firm Kura Oncology’s shares rose 4% to $8.31 yesterday, after it announced a research collaboration with Mirati Therapeutics. 3 November 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze